# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-329537
Filing Date
2026-08-03
Accepted
2026-08-03 07:11:48
Documents
79
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sptx-20260630.htm iXBRL | 10-Q | 3423627
2 | EX-31.1 | sptx-ex31_1.htm | EX-31.1 | 21465
3 | EX-31.2 | sptx-ex31_2.htm | EX-31.2 | 21494
4 | EX-32.1 | sptx-ex32_1.htm | EX-32.1 | 11296
5 | EX-32.2 | sptx-ex32_2.htm | EX-32.2 | 11306
| Complete submission text file | 0001193125-26-329537.txt |  | 11288792

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | sptx-20260630.xsd | EX-101.SCH | 1262107
83 | EXTRACTED XBRL INSTANCE DOCUMENT | sptx-20260630_htm.xml | XML | 1843515

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Filer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43254 | Film No.: 261230446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)